Coesia at CPHI 2026

From product processing to final packaging, Coesia supports the pharmaceutical industry with an ecosystem of technologies designed to meet growing demands for productivity, quality, traceability and regulatory compliance.

Integration and digitalization reshape pharmaceutical manufacturing. Addressing these challenges, Coesia’s participation in CPHI 2026 (6–8 October, Fiera Milano), will showcase its portfolio of technologies, expertise, and solutions for the pharmaceutical sector through Coesia Pharma Solutions & Healthcare, bringing together the Group's specialist capabilities dedicated to pharmaceutical manufacturing.

A growing market facing increasing complexity

According to Precedence Research, the global pharmaceutical market is expected to grow from USD 1.77 trillion in 2025 to more than USD 3 trillion by 2034, at a compound annual growth rate (CAGR) of 6.15%. This growth is being driven by the increasing prevalence of chronic diseases, the expansion of personalized medicine, and the growing adoption of biologics.

At the same time, the pharmaceutical manufacturing and packaging equipment market is experiencing strong growth, driven by evolving regulatory requirements, increasing process automation, and growing demand for more flexible and sustainable solutions.

Against this backdrop, pharmaceutical manufacturers must balance quality, regulatory compliance, productivity, and flexibility while responding quickly to changing market conditions and evolving regulatory requirements. This increasingly complex environment calls for a new approach to designing and managing manufacturing processes that bring together technologies, expertise, and integrated solutions.

Solutions built around customer needs

At CPHI, Coesia will present an approach that goes beyond individual technologies, focusing on integrating specialist expertise, solutions, and services to meet specific customer requirements. The Group’s portfolio includes technologies for filling, automated inspection, assembly, serialization, packaging, and end-of-line operations, enabling manufacturers to build coordinated solutions for defined production requirements.

Drawing on a portfolio of solutions developed by the Group's specialized companies, Coesia provides customers with a technology architecture that enables different technologies and expertise to work together more effectively. This model enhances production flow continuity, simplifies line scalability, and enables manufacturers to respond more effectively to the challenges of a rapidly evolving market.

From digitalization to highly specialized applications

Digitalization is one of the cornerstones of this vision. Manufacturing Execution Systems (MES), digital execution platforms, and advanced data management technologies enable manufacturers to increase process control, improve traceability, reduce the risk of human error, and support regulatory compliance, while laying the foundation for continuous operational improvement.

This approach also extends to highly specialized applications such as ophthalmics, where Coesia provides dedicated technologies for filling, inspection, and packaging of sterile products, developed to meet the stringent precision, quality, and compliance requirements of this market segment. By combining specialized expertise with application-specific technologies, Coesia enables manufacturers to effectively meet the demands of an increasingly dynamic production environment.

Coesia Pharma Solutions & Healthcare: integrated expertise for pharmaceutical manufacturing

Coesia Pharma Solutions & Healthcare brings together the expertise of FlexLink, G.D, GF, Hapa, MGS, Norden, AMACO, Enflex, and Autoware, combining the Group's specialist capabilities across pharmaceutical manufacturing and packaging.

Together, these companies provide complementary technologies and expertise spanning sterile filling, automated inspection, assembling, digital printing, serialization, packaging, product handling, and process digitalization.

"The pharmaceutical industry is changing profoundly. Digitalization, system integration, and stricter regulatory requirements are reshaping how manufacturers design and operate their production environments. With Coesia Pharma Solutions & Healthcare, we bring together complementary expertise and integrated technologies to develop solutions customized around specific customer needs," said Alessandro Parimbelli, CEO of Coesia.

"The pharmaceutical industry is becoming increasingly complex, but complexity should never become a barrier to growth," added Alberto Cirri, CEO of GF, a Coesia company. "Our role is to turn that complexity into a competitive advantage by providing manufacturers with reliable technologies, specialist expertise, and ongoing support throughout the entire development and industrialization journey."

CPHI Milan - Stand 9A92

Prodotti e tecnologie: GRUPPO COESIA

Gallery